Allergy Therapeutics plc (AIM:AGY)

Allergy Therapeutics Revenue

Allergy Therapeutics had revenue of 34.03M GBP in the half year ending December 31, 2024, a decrease of -14.71%. This brings the company's revenue in the last twelve months to 55.66M, up 4.50% year-over-year. In the fiscal year ending June 30, 2024, Allergy Therapeutics had annual revenue of 55.20M, down -7.36%.

• Revenue (ttm): 55.66M
• Revenue Growth: +4.50%
• P/S Ratio: 7.19
• Revenue / Employee: 90.94K
• Employees: 612
• Market Cap: 400.38M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	55.20M	-4.39M	-7.36%
Jun 30, 2023	59.59M	-13.18M	-18.11%
Jun 30, 2022	72.77M	-11.56M	-13.71%
Jun 30, 2021	84.33M	6.13M	7.83%
Jun 30, 2020	78.20M	4.49M	6.09%